The Tiny Cargo Company is harnessing the natural power and potential of milk exosomes.
Milk exosomes have been hiding in plain sight.
In a world first, they will soon be available at an industrial scale from The Tiny Cargo Company.
Exosomes were first defined in the 1980’s, and in 2007 the first milk-derived exosomes-based research was published. Their exceptional natural healing properties are able to bypass all internal barriers in the human body and there is growing evidence of the benefits exosomes deliver in:
Guidance and support in infant development
Enhancing muscle recovery
Promoting healthy bones
Adult gastrointestinal health support
Unique and powerful properties
Exosomes have unique properties that allow them to signal, target and offload vital therapies to the exact site where they’re needed most. They are:
- Naturally stable thanks to their lipid bilayer membrane
- Non-immunogenic, supporting stabilization
- Able to penetrate tissues/cells
- Highly biocompatible
Not only have we made the breakthrough in isolating exosomes from cow’s milk on an industrial scale, we’re also developing the technology to load potent therapeutics into exosomes creating a novel drug delivery platform.
Up until now exosome’s vast potential has been constrained due to cost and supply limitations – we’re changing that.
A world first innovation.
The Tiny Cargo Company has unlocked the therapeutic and nutraceutical potential of exosomes, using proprietary technology to isolate exosomes from cow’s milk on an industrial scale.
We expect commercial quantities of Tiny Cargo Company Exosomes to be available in late 2024.
Pure milk exosomes at accessible scale.
The science is clear - exosomes have a natural ability to carry proteins, lipids and nucleic acids, successfully delivering them to sites where they’re needed most. Thanks to The Tiny Cargo Company, these potent, natural carriers will soon be available at scale for the first time - opening up vast opportunities for the therapeutic and nutraceutical industries.
Highly experienced innovators.
We are the global leaders in the science, manufature and supply of mammalian milk exosomes for use in nutraceutical and therapeutic applications. Our team of leading scientists and biotechnicians are based in Virginia, USA.
We’re pioneering the isolation and science of exosomes to deliver targeted nutraceutical and pharmaceutical therapies that will have meaningful patient benefits.”
Rob Gourdie
Founder
Latest
developments.
We’re collaborating with a number of universities and research groups, as well as attending key scientific forums. Don’t miss out. Stay up to date with our latest developments